CancerCare Manitoba Foundation

1160-675 McDermot Ave
Winnipeg, MB R3E 0V9
President & CEO: Patti Smith
Board Chair: Lee Meagher

Charitable Reg. #:88688 6746 RR0001

STAR RATING

Ci's Star Rating is calculated based on the following independent metrics:

[Charity Rating: 3/5]

✔+

FINANCIAL TRANSPARENCY

Audited financial statements for current and previous years available on the charity’s website.

B-

RESULTS REPORTING

Grade based on the charity's public reporting of the work it does and the results it achieves.

n/r

DEMONSTRATED IMPACT

The demonstrated impact per dollar Ci calculates from available program information.

NEED FOR FUNDING

Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.

82%

CENTS TO THE CAUSE

For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 82 cents are available for programs.



My anchor

OVERVIEW

About CancerCare Manitoba Foundation:

CancerCare Manitoba is a 3-star charity. It has a B- results reporting grade, which is below average. Its overhead spending is within Ci’s reasonable range and it has reserve funds to cover its program costs for eight years and eleven months.

Founded in 1997, CancerCare Manitoba Foundation (CCMF) fundraises for CancerCare Manitoba (CCMB). CCMB is Manitoba’s provincially mandated agency for cancer and blood disorders. Contributions from CCMF help fund projects that are not eligible for government funding or that funding is not available for. These include prevention, early detection, clinical trials, and research. CCMF reports that all funds raised and donated remain in Manitoba. Since 2000, CCMF has granted over $208m to CCMB. CCMF funds four programs: Patient Experience, Local Research, Clinical Trials, and Prevention, Risk Reduction, and Awareness.

The following program information is from CCMF’s annual report for the fiscal year ending March 2023 (F2023). CCMF’s annual report for F2024 was not available at the time of this update. The program spending breakdown CCMF provides in its annual report does not reconcile with its audited financial statement. Ci reports the percentages for program spending from the F2023 annual report without the dollar values. 

CCMF reported that 48% of its program spending went to Patient Experience in F2023. This program focuses on supporting cancer patients and their families. These include educational resources and after-care programs to help patients. Alongside the Government of Manitoba, CCMF provides funding for a new Centre of Hope at the Western Manitoba Cancer Centre. The new Centre will help patients and families receive the emotional and physical support they need.

CancerCare Manitoba Foundation spent 46% of program spending on Local Research in F2023. CCMB reports that it has over 70 scientists researching cancer and blood disorders. CCMB has three interrelated research disciplines: Basic and Translational Research, Clinical Research, and Health Services Research.

CCMF spent 4% of program spending on Clinical Trials in F2023. Over 1,700 patients at CancerCare Manitoba are currently enrolled in clinical trials. CCMB reports that each year around 300 Manitobans enrol in around 120 clinical trials.

CCMF spent 2% of program spending on Prevention, Risk Reduction, and Awareness in F2023. This program focuses on ensuring access to screening programs and educational tools. The charity reports that if all Manitobans started eating healthy today, 1,300 cancer cases could be prevented in 2038.

My anchor

Results and Impact

CancerCare Manitoba Foundation reports that the donations it receives make a significant difference in changing the course of cancer in Manitoba. The charity reports that in Manitoba:

The five-year cancer survival rate is 64%, up from 55% in the early 1990s.

There is a 50% decline in prostate cancer deaths since 1995.

There is a 48% decline in breast cancer deaths since the 1980s.

While Ci highlights these key outcomes, they may not be a complete representation of CancerCare Manitoba Foundation’s results and impact.

This charity is not yet rated on impact (n/r).

My anchor

Finances

In the fiscal year ending March 2024 (F2024), CCMF received $21.3m in donations and special events revenue. CCMF also made $10.3m in investment income (32% of total revenue). Administrative costs are 7% of total revenue (excluding investment income) and fundraising costs are 11% of donations. Overhead spending is 18%, which is within Ci’s reasonable range. For every dollar donated, 82 cents are available for the cause. In F2024, CancerCare Manitoba Foundation granted $11.7m (36% of total revenue) to CancerCare Manitoba.

In F2024, CCMF had a surplus of $16.6m, which is 52% of total revenue, and reported no spending on capital expenditures.

At the end of F2024, CCMF has $103.5m in reserve funds (cash and investments). CCMF has enough reserve funds to cover 888% or eight years and eleven months of its annual program costs.

This charity report is an update that was sent to CancerCare Manitoba Foundation for review. Changes and edits may be forthcoming.

Updated on July 19, 2024 by Thea Clark.

Financial Review


Financial Ratios

Fiscal year ending March
202420232022
Administrative costs as % of revenues 7.2%6.8%10.0%
Fundraising costs as % of donations 10.9%10.5%21.1%
Total overhead spending 18.1%17.3%31.1%
Program cost coverage (%) 887.9%785.2%1,366.3%

Summary Financial Statements

All figures in $000s
202420232022
Donations 17,02414,8466,830
Government funding 000
Special events 4,2534,8174,301
Investment income 10,2953301,649
Other income 56923842
Total revenues 32,14120,23112,822
Program costs 000
Grants 11,65711,1005,965
Administrative costs 1,5641,3491,118
Fundraising costs 2,3262,0732,343
Other costs 000
Total spending 15,54714,5219,426
Cash flow from operations 16,5945,7093,396
Capital spending 000
Funding reserves 103,49887,16381,500

Note: UNREALIZED GAIN (LOSS) ON INVESTMENTS: Ci included unrealized gain (loss) on investments in investment income, affecting total revenue by $6.7m in F2024, ($2.1m) in F2023, and ($1.7m) in F2022. DEFERRED CONTRIBUTIONS: Ci included deferred contributions in donations, affecting total revenue by $47k in F2024, ($861) in F2023, and $50k in F2022. SPECIAL EVENTS: Ci reports gross events revenues. This increased total revenue and expenses by $1.1m in F2024, $1.0m in F2023, and $1.3m in F2022.

Salary Information

Full-time staff: 18

Avg. compensation: $106,275

Top 10 staff salary range:

$350k +
0
$300k - $350k
0
$250k - $300k
0
$200k - $250k
1
$160k - $200k
0
$120k - $160k
2
$80k - $120k
6
$40k - $80k
1
< $40k
0

Information from most recent CRA Charities Directorate filings for F2023

My anchor

Comments & Contact

Comments added by the Charity:

No comments have been added by the charity.

Charity Contact

Website: www.cancercarefdn.mb.ca
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 204-787-4143

Print  
Image

Charity Intelligence researches Canadian charities for donors to be informed and give intelligently. Our website posts free reports on more than 800 Canadian charities, as well as in-depth primers on philanthropic sectors like Canada’s environment, cancer, and homelessness. Today over 500,000 Canadians use our website as a go-to source for information on Canadian charities reading over 1.6 million charity reports. Through rigorous and independent research, Charity Intelligence aims to assist Canada’s dynamic charitable sector in being more transparent, accountable and focused on results.

 

Be Informed. Give Intelligently. Have Impact

 

Charitable Registration Number: 80340 7956 RR0001